Are you Dr. Shizuru?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-723-4000
Summary
- Dr. Judith Shizuru, MD is an oncologist in Stanford, California. She is currently licensed to practice medicine in California. She is an Associate Professor at Stanford.
Education & Training
Stanford University School of MedicineClass of 1992
Certifications & Licensure
CA State Medical License 1994 - 2026
American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- Belumosudil combination therapy for chronic graft-versus-host-disease in real-world clinical practice.Michelle M Chin, John S Tamaresis, Laura J Johnston, Robert Lowsky, Everett Meyer
Bone Marrow Transplantation. 2025-03-01 - Donor Regulatory T-Cell Therapy to Prevent Graft-Versus-Host Disease.Everett Meyer, Anna Pavlova, Alejandro Villar-Prados, Cameron S Bader, Bryan Xie
Blood. 2025-01-10 - 6 citationsA phase 1 clinical trial of NKTR-255 with CD19-22 CAR T-cell therapy for refractory B-cell acute lymphoblastic leukemia.Hrishikesh Srinagesh, Clayton Jackson, Parveen Shiraz, Nikeshan Jeyakumar, Mark Hamilton
Blood. 2024-10-17
Press Mentions
Fred Hutch Hosts Inaugural Dr. E. Donnall Thomas SymposiumOctober 7th, 2022- Study Predicts Who May Benefit from CAR-T Cell Therapy for Blood CancersAugust 2nd, 2021
Jasper Therapeutics Announces Upcoming Data Presentation on Lead Program, JSP191, at 61st American Society of Hematology (ASH) Annual Meeting & ExpositionDecember 9th, 2019- Join now to see all
